Titel

Merkliste
1 Ergebnisse

Oral ixazomib maintenance following autologous stem cell tr..:

Dimopoulos, Meletios A ; Gay, Francesca ; Schjesvold, Fredrik...
Dimopoulos , M A , Gay , F , Schjesvold , F , Beksac , M , Hajek , R , Weisel , K C , Goldschmidt , H , Maisnar , V , Moreau , P , Min , C K , Pluta , A , Chng , W-J , Kaiser , M , Zweegman , S , Mateos , M-V , Spencer , A , Iida , S , Morgan , G , Suryanarayan , K , Teng , Z , Skacel , T , Palumbo , A , Dash , A B , Gupta , N , Labotka , R , Rajkumar , S V , Abildgaard , N & TOURMALINE-MM3 study group 2019 , ' Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3) : a double-blind, randomised, placebo-controlled phase 3 trial ' , Lancet , vol. 393 , no. 10168 , pp. 253-264 . https://doi.org/10.1016/S0140-6736(18)33003-4. , 2019

Link: https://portal.findresearcher.sdu.dk/da/publications/b..

RT Journal
T1 <Title>Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3):a double-blind, randomised, placebo-controlled phase 3 trial</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftsydanskunivpub:oai:sdu.dk:publications_b364b10e-fb5d-49c4-a071-d3b09759a144&Exemplar=1&LAN=DE
				
A1 Dimopoulos, Meletios A
A1 Gay, Francesca
A1 Schjesvold, Fredrik
A1 Beksac, Meral
A1 Hajek, Roman
A1 Weisel, Katja Christina
A1 Goldschmidt, Hartmut
A1 Maisnar, Vladimir
A1 Moreau, Philippe
A1 Min, Chang Ki
A1 Pluta, Agnieszka
A1 Chng, Wee-Joo
A1 Kaiser, Martin
A1 Zweegman, Sonja
A1 Mateos, Maria-Victoria
A1 Spencer, Andrew
A1 Iida, Shinsuke
A1 Morgan, Gareth
A1 Suryanarayan, Kaveri
A1 Teng, Zhaoyang
A1 Skacel, Tomas
A1 Palumbo, Antonio
A1 Dash, Ajeeta B
A1 Gupta, Neeraj
A1 Labotka, Richard
A1 Rajkumar, S Vincent
A1 Abildgaard, Niels
YR 2019
K1 Administration
K1 Oral
K1 Antineoplastic Agents/administration & dosage
K1 Boron Compounds/administration & dosage
K1 Disease Progression
K1 Double-Blind Method
K1 Female
K1 Glycine/administration & dosage
K1 Humans
K1 Male
K1 Middle Aged
K1 Multiple Myeloma/drug therapy
K1 Stem Cell Transplantation
K1 Time Factors
K1 Transplantation
K1 Autologous
K1 Treatment Outcome
JF Dimopoulos , M A , Gay , F , Schjesvold , F , Beksac , M , Hajek , R , Weisel , K C , Goldschmidt , H , Maisnar , V , Moreau , P , Min , C K , Pluta , A , Chng , W-J , Kaiser , M , Zweegman , S , Mateos , M-V , Spencer , A , Iida , S , Morgan , G , Suryanarayan , K , Teng , Z , Skacel , T , Palumbo , A , Dash , A B , Gupta , N , Labotka , R , Rajkumar , S V , Abildgaard , N & TOURMALINE-MM3 study group 2019 , ' Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3) : a double-blind, randomised, placebo-controlled phase 3 trial ' , Lancet , vol. 393 , no. 10168 , pp. 253-264 . https://doi.org/10.1016/S0140-6736(18)33003-4
LK http://dx.doi.org/https://portal.findresearcher.sdu.dk/da/publications/b364b10e-fb5d-49c4-a071-d3b09759a144
DO https://portal.findresearcher.sdu.dk/da/publications/b364b10e-fb5d-49c4-a071-d3b09759a144
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)